Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03712891 · ClinicalTrials.gov registry record · NA
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
A NA study, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT03712891: Completed NA study, sponsored by TriHealth.
NCT03712891 is a NA study that has completed, run by TriHealth. The registered enrollment target is 178 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03712891, a NA study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).
Primary Outcome
Post-anesthesia Care Unit length of stay
Interventions
- DIETARY_SUPPLEMENT Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2023-08-16 |
| Phase | NA |
What the finished NCT03712891 record still lists
NCT03712891 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Coffee is the first listed.
NCT03712891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03712891 about?
NCT03712891 is a clinical study titled "Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU". The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).
What is the current status of trial NCT03712891?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2018-10-25. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT03712891?
The interventions under investigation include: Coffee (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03712891?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03712891's enrollment target sits among peer trials
178 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI